» Articles » PMID: 35121902

APOBEC3A Drives Deaminase Domain-independent Chromosomal Instability to Promote Pancreatic Cancer Metastasis

Abstract

Despite efforts in understanding its underlying mechanisms, the etiology of chromosomal instability (CIN) remains unclear for many tumor types. Here, we identify CIN initiation as a previously undescribed function for APOBEC3A (A3A), a cytidine deaminase upregulated across cancer types. Using genetic mouse models of pancreatic ductal adenocarcinoma (PDA) and genomics analyses in human tumor cells we show that A3A-induced CIN leads to aggressive tumors characterized by enhanced early dissemination and metastasis in a STING-dependent manner and independently of the canonical deaminase functions of A3A. We show that A3A upregulation recapitulates numerous copy number alterations commonly observed in patients with PDA, including co-deletions in DNA repair pathway genes, which in turn render these tumors susceptible to poly (ADP-ribose) polymerase inhibition. Overall, our results demonstrate that A3A plays an unexpected role in PDA as a specific driver of CIN, with significant effects on disease progression and treatment.

Citing Articles

3A or not 3A: Cytidine deaminases in the etiology of the CAG-repeat expansion diseases.

Usdin K Proc Natl Acad Sci U S A. 2025; 122(9):e2426776122.

PMID: 39993205 PMC: 11892648. DOI: 10.1073/pnas.2426776122.


Advances in Vaccine-Based Therapies for Pancreatic Cancer.

McMillan M, Soares K J Gastrointest Cancer. 2025; 56(1):62.

PMID: 39939414 PMC: 11821674. DOI: 10.1007/s12029-025-01165-4.


An overview of the functions and mechanisms of APOBEC3A in tumorigenesis.

Yang Y, Liu N, Gong L Acta Pharm Sin B. 2024; 14(11):4637-4648.

PMID: 39664421 PMC: 11628810. DOI: 10.1016/j.apsb.2024.08.020.


Spatial immune heterogeneity in a mouse tumor model after immunotherapy.

Smahel M, Johari S, Smahelova J, Pfeiferova L, Nunvar J Cancer Sci. 2024; 116(3):622-632.

PMID: 39624899 PMC: 11875765. DOI: 10.1111/cas.16421.


Adenine base editors induce off-target structure variations in mouse embryos and primary human T cells.

Wu L, Jiang S, Shi M, Yuan T, Li Y, Huang P Genome Biol. 2024; 25(1):291.

PMID: 39529170 PMC: 11552398. DOI: 10.1186/s13059-024-03434-0.


References
1.
Alexandrov L, Nik-Zainal S, Wedge D, Aparicio S, Behjati S, Biankin A . Signatures of mutational processes in human cancer. Nature. 2013; 500(7463):415-21. PMC: 3776390. DOI: 10.1038/nature12477. View

2.
Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y . The repertoire of mutational signatures in human cancer. Nature. 2020; 578(7793):94-101. PMC: 7054213. DOI: 10.1038/s41586-020-1943-3. View

3.
Harris R, Liddament M . Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004; 4(11):868-77. DOI: 10.1038/nri1489. View

4.
Hingorani S, Petricoin E, Maitra A, Rajapakse V, King C, Jacobetz M . Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2004; 4(6):437-50. DOI: 10.1016/s1535-6108(03)00309-x. View

5.
Rhim A, Mirek E, Aiello N, Maitra A, Bailey J, McAllister F . EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1-2):349-61. PMC: 3266542. DOI: 10.1016/j.cell.2011.11.025. View